Bergamo Lymphoid Cancer Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorA.O. Ospedale Papa Giovanni XXIII
About this trial
This registry has been established to gain a better understanding of the clinical and biological characteristics and outcome of patients with lymphoid cancer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female patients 18 years or older
Written informed consent
Confirmed diagnosis of Hodgkin disease, non-Hodgkin lymphomas or myeloma
Disqualifiers
None
Trial population
Patients eligible for this study are patients with a diagnosis of lymphoid cancer in charge of the Hematology and Bone Marrow Transplant Unit "Ospedale Papa Giovanni XIII" of Bergamo.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Patient registry
Other interventionClinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Treatment groups
6,000 Participants
are divided into 3 treatment groupsGroup A: Hodgkin lymphoma1 intervention
Group B: Non-Hodgkin lymphoma1 intervention
Group C: Myeloma1 intervention
Trial outcomes
Primary outcomes
1
Overall survival
Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to intervention and baseline characteristics
Time frame
20 yearsSecondary outcomes
1
Disease-free survival
Analyzed only for patients in complete response, as time from achievement of the complete response to relapse or death due to disease or acute toxicity of treatment, stratified according to intervention and baseline characteristics
Time frame
20 years2
Progression-free survival
Analyzed for all patients, as time from diagnosis to progression of disease or death as a result of any cause, stratified according to intervention and baseline characteristics
Time frame
20 years3
Biological correlative studies
Association between clinical and biologic characteristics
Time frame
20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov